Lenvatinib
产品名称:Lenvatinib
产品描述:
产品描述 | Lenvatinib is a Kinase Inhibitor. The mechanism of action of lenvatinib is as a Receptor Tyrosine Kinase Inhibitor. | ||||||||||||||||
靶点活性 | PDGFRβ:39 nM, VEGFR1/FLT1:22 nM, FGFR1:46 nM, VEGFR2/KDR:4.0 nM, VEGFR3/FLT4:5.2 nM | ||||||||||||||||
体外活性 | 与血管内皮生长因子抗体和伊马替尼处理相比,100 mg/kg E7080处理降低微脉管密度效果更好.用30和100 mg/kg E7080口服给药处理H146 移植瘤模型,可以剂量依赖性抑制H146生长,100 mg/kg时导致退化
| ||||||||||||||||
体内活性 | 体外受体酪氨酸和丝/苏氨酸激酶实验中,E7080抑制Flt-1,KDR和Flt-4,IC50分别为22,4.0和5.2 nM。究显示,1 μM和10 μM E7080通过抑制FGFR和PDGFR信号通路明显抑制细胞迁移和入侵。E7080有效抑制血管生成,也明显抑制VEGF/KDR和SCF/KIT信号通路。E7080也抑制FGFR1和PDGFR酪氨酸激酶,作用于FGFR1,PDGFRα和PDGFRβ时,IC50分别为46,51和100 nM。E7080分别作用于由血管内皮生长因子和血管内皮生长因子-C刺激的HUVECs,有效抑制VEGFR2和VEGFR3磷酸化,IC50分别为0.83 nM和0.36 nM。
| ||||||||||||||||
激酶实验 | In vitro kinase assay [1]: Tyrosine kinase assays are performed by HTRF (KDR, VEGFR1, FGFR1, c-Met, EGFR) and ELISA (PDGFRβ), using the recombinant kinase domains of receptors. In both assays, 4 μL of serial dilutions of E7080 are mixed in a 96-well round plate with 10 μL of enzyme, 16 μL of poly (GT) solution (250 ng) and 10 μL of ATP solution (1 μM ATP) (final concentration of DMSO is 0.1%). In wells for blanks, no enzyme is added. In control wells no test article is added. The kinase reaction is initiated by adding ATP solution to each well. After 30-minute incubation at 30°C, the reaction is stopped by adding 0.5 M EDTA (10 μL/well) to the reaction mixture in each well. Dilution buffer adequate to each kinase assay is added to the reaction mixture. In the HTRF assay, 50 μL of the reaction mixture is transferred to a 96-well 1/2 area black EIA/RIA plate, HTRF solution (50 μL/well) is added to the reaction mixture, and then kinase activity is determined by measurement of fluorescence with a time-resolved fluorescence detector at an excitation wavelength of 337 nm and an emission wavelengths of 620 and 665 nm. In the ELISA, 50 μL of the reaction mixture is incubated in avidin coated 96-well polystyrene plates at room temperature for 30 minutes. After washing with wash buffer, PY20-HRP solution (70 μL/well) is added and the reaction mixture is incubated at room temperature for 30 minutes. After washing with wash buffer, TMB reagent (100 μL/well) is added to each well. After several minutes (10–30 minutes), 1 M H3PO4 (100 μL/well) is added to each well. Kinase activity is determined by measurement of absorbance at 450 nm with a microplate reader. | ||||||||||||||||
细胞实验 | HUVECs (1,000 cells in each well in serum-free medium containing 2% fetal bovine serum) and L6 rat skeletal muscle myoblasts (5,000 cells in each well in serum-free DMEM) are dispensed in a 96-well plate and incubated overnight. E7080 and either VEGF (20 ng/mL) or FGF-2 (20 ng/mL) containing 2% fetal bovine serum and PDGFβ (40 ng/mL) are added to each well. Cells are incubated for 3 days and then the ratios of surviving cells are measured by WST-1 reagent. For proliferation assay, samples are duplicated and three separate experiments are done. (Only for Reference) |
别名 | 仑伐替尼, E7080 |
化合物与蛋白结合的复合物 | FGFR-1 in complex with ligand lenvatinib |
分子量 | 426.86 |
分子式 | C21H19ClN4O4 |
CAS No. | 417716-92-8 |
存储
| Powder: -20°C for 3 years | In solvent: -80°C for 2 years
溶解度
DMSO: 38 mg/mL (89 mM)
Ethanol: <1 mg/mL
( < 1 mg/mL refers to the product slightly soluble or insoluble )
联系我们:
邮箱:2519696869@qq.com
QQ: 2519696869
电话:18066853083
微信:18066853083
公司介绍:
西安齐岳生物科技有限公司是集化学科研和定制与一体的高科技化学公司。业务范围包括化学试剂和产品的研发、生产、销售等。涉及产品为通用试剂的分销、非通用试剂的定制与研发,涵盖生物科技、化学品、中间体和化工材料等领域。
主营产品:COF、MOF单体系列:三蝶烯衍生物、金刚烷衍生物、四苯甲烷衍生物、peg、上转换、石墨烯、光电材料、点击化学、凝集素、载玻片、蛋白质交联剂、脂质体、蛋白、多肽、氨基酸、糖化学等。